Advances in Targeted Immunotherapies for Cancer Treatment
American Journal Of Pharmacy And Pharmacology · 31.12.2023 · 4 (6) · 9-12
DOI: 10.71465/ajpp.2829 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal Of Pharmacy And Pharmacology, online erschienen am 31.12.2023. Verfasst von Dr. Rami Al-Farouq.
Abstract (Originalsprache)
Targeted immunotherapies represent a major breakthrough in cancer treatment, offering precise and personalized approaches to combating malignancies. These therapies enhance the body’s immune system to recognize and eliminate cancer cells with minimal damage to normal tissues. Recent advances include immune checkpoint inhibitors, CAR-T cell therapies, bispecific antibodies, and cancer vaccines. This article explores the mechanisms, clinical applications, challenges, and future directions of targeted immunotherapies in oncology.
Zitieren
APA
Al-Farouq, D. R. (2023). Advances in Targeted Immunotherapies for Cancer Treatment. American Journal Of Pharmacy And Pharmacology, 4(6), 9-12. https://doi.org/10.71465/ajpp.2829
Vancouver
Al-Farouq DR. Advances in Targeted Immunotherapies for Cancer Treatment. American Journal Of Pharmacy And Pharmacology. 2023;4(6):9-12. doi:10.71465/ajpp.2829
BibTeX
@article{AlFarouq2023,
author = {Al-Farouq, Dr. Rami},
title = {Advances in Targeted Immunotherapies for Cancer Treatment},
journal = {American Journal Of Pharmacy And Pharmacology},
year = {2023},
volume = {4},
number = {6},
pages = {9--12},
doi = {10.71465/ajpp.2829}
}
EUVIMED